Replacing 50-year-old chemical diagnostics, such as PCR and antigen tests, with printed nanosensors is expected to significantly disrupt the $50-billion diagnostics industry, not only for COVID-19 but for a wide range of diseases, said IdentifySensors Biologics CEO, Gregory Hummer, MD.
"We are excited to announce that we have proven this breakthrough concept and have moved into the large-scale manufacturing stage," Dr. Hummer said. "Purdue University has been a great partner helping with the development. We will continue working with the university's scientists on a series of sensors for additional pathogens on this platform."
IdentifySensors Biologics has applied the new technology to a commercial device called Check4™, an over-the-counter reusable reader that integrates with a consumer's smartphone. Single-use test cartridges, which will be sold separately, slide into the reusable reader and send test results from a saliva sample wirelessly to a phone in minutes.
MEDIA & PRESS INQUIRES
CONNECT WITH IDENTIFYSENSORS
Communications: Joe Mosbrook (216) 375-2141 mosbrook@acclaimllc.comRelated Articles
Ohio doctor develops fast self-testing for COVID-19
MEDIA & PRESS INQUIRES CONNECT WITH IDENTIFYSENSORS Communications: Joe Mosbrook (216) 375-2141 mosbrook@acclaimllc.comRelated Articles
Check4-COVID by IdentifySensors Biologics Allows For Accurate Results Within Minutes On Your Phone
MEDIA & PRESS INQUIRES CONNECT WITH IDENTIFYSENSORS Communications: Joe Mosbrook (216) 375-2141 mosbrook@acclaimllc.comRelated Articles
Bloomberg Business – IdentifySensors Biologics Develops Fast, Accurate, Over-the-counter RNA COVID Self-test
MEDIA & PRESS INQUIRES CONNECT WITH IDENTIFYSENSORS Communications: Joe Mosbrook (216) 375-2141 mosbrook@acclaimllc.comRelated Articles